BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to prescription drug pricing and value Prescription drug manufacturing and supply chains Issues related to 340B program Issues related to tax and tariffs Issues related to Intellectual Property Issues related to Inflation Reduction Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHARINE TROLLER BOND | — |
| CHRISTOPHER CUNNINGHAM | — |
| SARAH ELIZABETH NORDSTROM | — |
Medicare/Medicaid MMM
Education about chronic kidney disease and Medicare screening guidelines Issues related to Medicare Part D redesign Issues related to prescription drug pricing and value Issues regarding implementation of the Inflation Reduction Act, including H.R. 1492/S.832 - EPIC Act of 2025 Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHARINE TROLLER BOND | — |
| CHRISTOPHER CUNNINGHAM | — |
| SARAH ELIZABETH NORDSTROM | — |
Animals ANI
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Far, Food and National Security Act of 2024 (H.R. 8467) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT BENNETT | — |
| BILL DAVIS | — |
Budget/Appropriations BUD
Issues related to FY2026 Appropriations
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT BENNETT | — |
| KATHARINE TROLLER BOND | — |
| CHRISTOPHER CUNNINGHAM | — |
| BILL DAVIS | — |
| SARAH ELIZABETH NORDSTROM | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.